Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-20

Clinical Trial Update: Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Belotero Basic to Juvéderm Ultra 3 assessing non-inferiority for facial wrinkles, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belotero Basic (Hyaluronic acid dermal filler)
  • Juvéderm Ultra 3 (Hyaluronic acid dermal filler)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Physiological Stress, Disorder of Aging | Phase 4 | Status: COMPLETED